News
Setback to Torrent: CDSCO Panel Rejects Phase III Waiver Plea for Prucalopride Over Safety Data Gaps
This came after Torrent Pharmaceuticals presented a proposal for a grant of permission to manufacture and market Prucalopride ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback